Bio-Techne TECH Ratios & Valuation
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 65%-0.8pp | 65.2%-0.4pp | 65.4%-0.1pp | 64.8%-1.6pp | 65.8%-1.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 4.5×+0.8× | 4.5×+0.6× | 4.2×-0.3× | 3.5×-0.4× | 3.7×-0.4× | |
| Valuation | ||||||
| Market capitalization | $8.18B-11.8% | $9.16B-19.9% | $8.66B-31.4% | $7.84B-30.5% | $9.27B-16.3% | |
| Price / sales | 6.8×-0.9× | 7.5×-2.0× | 7.1×-3.7× | 6.4×-3.3× | 7.7×-1.9× | |
| Dividend yield | 0.6%+0.1pp | 0.5%+0.1pp | 0.6%+0.2pp | 0.6%+0.2pp | 0.5%+0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Bio-Techne's profit margins?
- Bio-Techne (TECH) runs a 65.0% gross margin and a 14.2% operating margin, with a 10.9% net margin.
- Where do Bio-Techne's ratios come from?
- Every ratio is computed from Bio-Techne's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
